Life at 100.4: An Immersive Social Virtual Reality (VR) Education Tool for Adolescent and Young Adult Cancer Patients and Caregivers

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Yale University
Study ID
NCT07224204
Status
Recruiting

Conditions

  • Adolescent Cancer
  • Cancer
  • Young Adult Cancer

Eligibility Criteria

Sex
ALL
Age
13 Years - 39 Years
Healthy Volunteers
Not accepted

Interventions

  • Life at 100.4 — BEHAVIORAL
    An Immersive Social Virtual Reality Education Tool, participation up to 2 hours

Study Details

The purpose of this study is to design and Beta test the Life at 100.4, an immersive social virtual reality education tool, with an anticipated 5 patient-caregiver-provider triads.Patients at Yale Pediatric Hematology and Oncology with a new oncologic diagnosis and their caregivers will be eligible for enrollment. Investigators will determine the feasibility and acceptability of implementing Life at 100.4 using validated measures.

Key Dates

Start date
Feb 11, 2026
Status verified
Feb 2026
Primary completion
Apr 30, 2027
Completion
Apr 30, 2027

Study Design

Enrollment
45 participants (estimated)
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE

Arms

  • No Intervention: Objective 1: Focus groups
    Participants will participate in a 45 minute to 1-hour long focus group with similar stake holders to inform the intervention. These groups will take place via Zoom teleconferencing software, have 4-6 participants per group and will be run by appropriately trained study staff.
  • Experimental: Objective 3:
    Beta testing of VR-based educational intervention, Life at 100.4, to improve understanding of fever with neutropenia, how and when to check for it, and what to do when they have a fever.

Primary Outcome Measure

Multimodal Presence Scale for Virtual Environments [ Time Frame: immediately post-intervention, up to 2 hours ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Pediatric Hematology/Oncology Clinic in Smilow Cancer HospitalNew HavenConnecticut06520-

Find similar trials in New Haven, CT

Related Studies